Search by Drug Name or NDC
NDC 55566-8403-01 FIRMAGON Details
FIRMAGON
FIRMAGON is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ferring Pharmaceuticals Inc.. The primary component is .
MedlinePlus Drug Summary
Degarelix injection is used to treat advanced prostate cancer (cancer that begins in the prostate [a male reproductive gland]). Degarelix injection is in a class of medications called gonadotropin-releasing hormone (GnRH) receptor antagonists. It works by decreasing the amount of testosterone (a male hormone) produced by the body. This may slow or stop the spread of prostate cancer cells that need testosterone to grow.
Related Packages: 55566-8403-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Degarelix Injection
Product Information
| NDC | 55566-8403 |
|---|---|
| Product ID | 55566-8403_bd21743c-94d0-4b84-a317-57d374a348b1 |
| Associated GPIs | 21405525102131 |
| GCN Sequence Number | 064873 |
| GCN Sequence Number Description | degarelix acetate VIAL 120 MG SUBCUT |
| HIC3 | V1V |
| HIC3 Description | ANTINEOPLASTIC LHRH(GNRH) ANTAGONIST,PITUIT.SUPPRS |
| GCN | 16946 |
| HICL Sequence Number | 036138 |
| HICL Sequence Number Description | DEGARELIX ACETATE |
| Brand/Generic | Brand |
| Proprietary Name | FIRMAGON |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Degarelix |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | KIT |
| Route | n/a |
| Active Ingredient Strength | n/a |
| Active Ingredient Units | n/a |
| Substance Name | n/a |
| Labeler Name | Ferring Pharmaceuticals Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA022201 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 55566-8403-01 (55566840301)
| NDC Package Code | 55566-8403-1 |
|---|---|
| Billing NDC | 55566840301 |
| Package | 1 KIT in 1 CARTON (55566-8403-1) * 3 mL in 1 VIAL, GLASS * 3 mL in 1 SYRINGE |
| Marketing Start Date | 2009-03-02 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |